← Leaderboards
Tariq Shafi
Johns Hopkins University
$4,022,444
Attributed
$6,172,889
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2010–23$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,172,889 · 4
By mechanism
R01$5,117,895 · 2
K23$903,999 · 1
R03$150,995 · 1
Top collaborators
- Eugene P. Rhee5 shared
- Eliseo Guallar2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Luis Andres Garza$9,883,093
- Neil R. Powe$19,036,767
- Anne M Murphy$9,234,720
- Harry A. Silber$1,318,402
- Mark Jeffrey Kohr$3,584,726
Others in their field
Top investigators on “Hemodialysis”
- Gerald J Beck · Cleveland Clinic Foundation$25,607,449
- Laura M Dember · Univ Of North Carolina Chapel Hill$15,973,453
- Sanjay Misra · Mayo Clinic Rochester$12,663,075
- Myles S Wolf · Duke University$11,798,574
- Stuart Johnston Knechtle · University Of Wisconsin Madison$11,789,092
- Alfred K. Cheung · University Of Utah$11,215,629
Research focus
HemodialysisDesignKidneyDialysis PatientsMeasurementDialysis ProcedurePreventEnd Stage Renal FailureKidney DiseasesAffectParticipantToxinDoseFundingRandomizedClinical TrialsEpidemiologyKidney FailureMorbidity - Disease RateCessation Of LifeUnited States National Institutes Of HealthAreaInsightFollow-Up
Grant awards (15)
Metabolomics of Uremic Symptoms in Dialysis Patients$538,379
R01 · FY2023 · NR
Metabolomics of Uremic Symptoms in Dialysis Patients$568,701
R01 · FY2022 · NR
Metabolomics of Uremic Symptoms in Dialysis Patients$537,959
R01 · FY2020 · NR
CAMARO-ESRD: Cardiac Arrhythmia Monitoring and Related Outcomes in End Stage Renal Disease Patients$761,467
R01 · FY2019 · HL
Metabolomics of Uremic Symptoms in Dialysis Patients$540,865
R01 · FY2019 · NR
CAMARO-ESRD: Cardiac Arrhythmia Monitoring and Related Outcomes in End Stage Renal Disease Patients$760,938
R01 · FY2018 · HL
Metabolomics of Uremic Symptoms in Dialysis Patients$592,581
R01 · FY2018 · NR
CAMARO-ESRD: Cardiac Arrhythmia Monitoring and Related Outcomes in End Stage Renal Disease Patients$817,005
R01 · FY2017 · HL · contact PI
Volume Management in Dialysis Patients Guided by Pulse Amplitude Ration$81,000
R03 · FY2016 · DK · contact PI
Volume Management in Dialysis Patients Guided by Pulse Amplitude Ration$69,995
R03 · FY2015 · DK · contact PI
Residual Kidney Function in ESRD: Measurements, Serum Markers and Outcomes$182,125
K23 · FY2014 · DK · contact PI
Residual Kidney Function in ESRD: Measurements, Serum Markers and Outcomes$182,558
K23 · FY2013 · DK · contact PI
Residual Kidney Function in ESRD: Measurements, Serum Markers and Outcomes$179,623
K23 · FY2012 · DK · contact PI
Residual Kidney Function in ESRD: Measurements, Serum Markers and Outcomes$180,761
K23 · FY2011 · DK · contact PI
Residual Kidney Function in ESRD: Measurements, Serum Markers and Outcomes$178,932
K23 · FY2010 · DK · contact PI